Integrative Breathwork Intervention for Chronic Pain
Developing and Testing a Multicomponent Breathwork Intervention for Adults With Chronic Pain
2 other identifiers
interventional
19
1 country
1
Brief Summary
The proposed research is to develop and refine a multicomponent breathwork intervention, Guided Respiration Mindfulness Therapy, and to iteratively evaluate its feasibility, acceptability, and plausibility for clinically significant effects in people with chronic low back pain. This integrative breathwork intervention involves a 60-minute breathing session where the focus is to maintain a conscious connected breathing pattern (no pause between inhale and exhale), apply mindful acceptance to somatic sensations, and relax any physical tension. Each breathwork session will be delivered 1-on-1 in person by a trained facilitator. The treatment consists of 8 breathwork sessions, once per week for 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
October 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2026
CompletedApril 14, 2026
April 1, 2026
1.1 years
July 30, 2024
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Treatment Acceptability
Treatment acceptability and participant satisfaction of the breathwork intervention will be measured using the Client Satisfaction Questionnaire and several face valid items. (0-10; higher values = greater treatment acceptability and satisfaction).
Post-treatment (after the 8-week intervention)
Intervention Adherence
Percentage of intervention sessions attended by participants.
Post-treatment (Week 8)
Participant Retention
Percentage of randomized participants who complete post-treatment assessment.
Post-treatment (Week 8)
Change in Pain Intensity
The Pain, Enjoyment, and General Activities (PEG-3) scale will be used to assess pain intensity over the past week on average. (0-10; higher values = greater pain intensity).
Change from Baseline (Week 0) to Post-treatment (Week 8), 1-month follow-up.
Change in Pain Interference
The Pain, Enjoyment, and General Activities (PEG-3) will be used assess pain interference over the past week. (0-10; higher values = greater pain interference).
Change from Baseline (Week 0) to Post-treatment (Week 8), 1-month follow-up.
Secondary Outcomes (15)
Treatment Credibility
After Intervention session 3
Acute Treatment Effects
Before and after each intervention sessions (Weeks 1-8)
Change in Pain Catastrophizing
Change from Baseline (Week 0) to Post-treatment (Week 8), 1-month follow-up.
Change in Pain Self-Efficacy
Change from Baseline (Week 0) to Post-treatment (Week 8), 1-month follow-up.
Change in Fear Avoidance Beliefs
Change from Baseline (Week 0) to Post-treatment (Week 8), 1-month follow-up.
- +10 more secondary outcomes
Other Outcomes (1)
Psychological Insight
Post-treatment (Week 8)
Study Arms (1)
Integrative Breathwork Intervention
EXPERIMENTALThe integrative, multicomponent breathwork intervention that will be tested in this study is called Guided Respiration Mindfulness Therapy. Participants will receive a 60 minute breathwork session once a week for 8 weeks.
Interventions
GRMT has three core components: respiratory regulation (i.e., sustained conscious connected breathing pattern into the upper chest where there is no pause between inhale and exhale), mindfulness of somatic sensations while breathing (i.e., interoceptive awareness with acceptance), and relaxation of physical tension. These components are the primary focus in every breathwork session. The intervention is delivered 1-on-1 in-person with a trained facilitator. Participants lay supine throughout the 60 minute session. The facilitator observes the participant's breathing pattern and guides the participant to apply the three core components. Each session ends with spontaneous, relaxed breathing and an opportunity to briefly share what happened during the session.
Eligibility Criteria
You may qualify if:
- Men and women 18-70 years of age.
- Chronic primary low back pain that has persisted for at least 3 months and on most days for the past 6 months.
- Average pain intensity of ≥ 4/10 for the past month.
- Fluent in English.
- Access to internet with a valid email address.
- Able to lay down and stay relatively still for one hour.
You may not qualify if:
- Leg pain, or any other chronic pain, that is greater than low back pain.
- Back pain possibly due to specific conditions (e.g., cancer, infection).
- Ongoing legal action or disability claim related to low back pain.
- Neurological symptoms associated with low back pain, including loss of control or incontinence of bowel or bladder.
- Systemic rheumatic disease/condition (e.g. rheumatoid arthritis, systemic lupus erythematosus, fibromyalgia).
- Respiratory disorder (e.g., chronic obstructive pulmonary disease) or moderate to severe asthma within the past 12 months.
- Activity limiting heart disease including cardiovascular or peripheral arterial disease.
- Uncontrolled hypertension (i.e. SBP/DBP of \> 160/95) or orthostatic hypotension (e.g., issues with fainting).
- Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy, history of seizures) or evidence of previous brain injury, including stroke and traumatic brain injury.
- Serious acute physical injuries or any surgery within the past 6 months.
- Serious psychiatric disorder (e.g., schizophrenia) or mental health issues requiring hospitalization within the past 12 months or currently on anti-psychotic medications.
- History of hospitalization or treatment of substance use disorder within the past 12 months.
- Currently undergoing curative or palliative chemotherapy or radiation. Pregnant or plan to become pregnant during the study period.
- Glaucoma or detached retina.
- Current participation or participation in the past 2 months of an interventional research study.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Pratscher, PhD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 9, 2024
Study Start
October 24, 2024
Primary Completion
December 10, 2025
Study Completion
January 9, 2026
Last Updated
April 14, 2026
Record last verified: 2026-04